CALCULATE YOUR SIP RETURNS

Earkart IPO Allotment Status

Written by: Kusum KumariUpdated on: 30 Sept 2025, 3:09 am IST
Earkart IPO opened on September 25, 2025, with a ₹49.26 crore fixed price issue at ₹135 per share. Allotment is expected on September 30, 2025, and listing is set for October 3, 2025, on BSE SME.
Earkart IPO Allotment Status
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

 Earkart IPO is a fixed-price issue totalling ₹49.26 crore. The IPO comprises a fresh issue of 31.30 lakh equity shares and an offer for sale of 3.34 lakh shares.

The IPO subscription window opened on September 25, 2025, and closed on September 29, 2025. The basis of allotment is expected to be finalised on September 30, 2025, and shares are likely to list on the BSE SME platform on October 3, 2025.

The issue price is ₹135 per share, with a lot size of 1,000 shares. The minimum investment for retail investors is ₹2,70,000 (2,000 shares), while the minimum HNI investment is ₹4,05,000 (3,000 shares).

How to Check Earkart IPO Allotment Status Online on NSE?

  • Go to the application status page
  • Select "Equity and SME IPO bids"
  • Choose "Earkart" from the Issue Name dropdown
  • Provide your Application Number or PAN
  • Click on Submit 

How to Check Earkart IPO Allotment Status Online on BSE?

  • Go to the application status page
  • Select "Equity" under the Issue Type
  • Choose "Earkart" from the Issue Name dropdown
  • Provide your Application Number or PAN
  • Click on “I am not a robot” and submit 

How to Check Earkart IPO Allotment Status Online on the Registrar’s Website?

  • Go to the registrar’s official website.
  • Select "Earkart" from the company list.
  • Enter your Client ID, Application Number, or PAN.
  • Click on Submit. 

Earkart IPO Details

Earkart Ltd. is entering the capital markets with a ₹49.26 crore IPO, structured as a fixed-price issue. The offering comprises a fresh issue of 31.30 lakh equity shares and an offer for sale of 3.34 lakh shares.

The IPO opened for subscription on September 25, 2025, and closed on September 29, 2025. The basis of allotment is expected to be finalised on September 30, 2025, and the company’s stock is likely to debut on the BSE SME platform on October 3, 2025.

The issue price is ₹135 per share, with a lot size of 1,000 shares. Retail investors can participate with a minimum investment of ₹2,70,000 (2,000 shares), while HNIs need to apply for at least ₹4,05,000 (3,000 shares). 

Allocation Quota for Earkart

The table below breaks down the Earkart share allocation for different categories, highlighting the number of shares and their percentage of the total issue. However, the key focus remains on the quotas allocated to retail investors and HNIs, as they are the most relevant for individual investors. 

Investor CategoryShares Offered 
Market Maker1,85,000 (5.07%)
NII (HNI)17,32,000 (47.47%)
Retail17,32,000 (47.47%)
Total36,49,000 (100.00%)

Data Source: NSE 

Earkart IPO – Overall Subscription Status

CategorySubscription (times)
NII*1.63
Individual Investor0.35
Total1.28

Note: The subscription details are as of September 29, 2025

Earkart Business Overview

Earkart Limited is a HealthTech company specialising in hearing aids and related accessories, offering a wide range of modern devices such as Receiver-In-Canal (RIC), Invisible (IIC), Behind-The-Ear (BTE), In-The-Ear (ITE), In-The-Canal (ITC), and Completely-In-Canal (CIC) hearing aids. In addition, the company provides products like adjustable foldable walkers and educational tools, including Multi-Sensory Integrated Educational Development (MSIED) kits and Teaching Learning Materials (TLM) for individuals with physical challenges.

Earkart distributes its products through an extensive network of partners and clinics across India and internationally. It is also a trusted supplier to the Government e-Market (GeM), providing hearing aids to ALIMCO under the Ministry of Social Justice and Empowerment. In April 2024, the company introduced its Shop-in-Shop (SIS) model, offering franchise opportunities to opticians and ENT/optical clinics. Currently, Earkart operates 49 SIS clinics across 22 cities in six states and two Union Territories, including Haryana, Uttar Pradesh, Rajasthan, Punjab, Jharkhand, Delhi, Uttarakhand, and Chandigarh.

The company’s manufacturing facility is located in Noida, spanning 4,500 square feet. Earkart’s competitive strengths include a diverse portfolio of hearing aids, a multi-channel distribution network encompassing online, offline, and B2G sales, and a strong focus on technological innovation and product development.

Know more about IPO allotment status and check your application details online for the latest updates on share allocation. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Published on: Sep 29, 2025, 9:39 PM IST

Kusum Kumari

Kusum Kumari is a Content Writer with 4 years of experience in simplifying financial market concepts. Currently crafting insightful content at Angel One, She specialise in breaking down complex topics into easy-to-understand pieces, blending expertise in market fundamentals and technical analysis.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers